Abnormalities in cytokine secretion from mesenchymal stem cells in psoriatic skin lesions.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  EJD. European journal of dermatology

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1684/ejd.2013.2149PMID 24135516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EGFR regulation of epidermal barrier function.

  2012cited by this paper
• Effect of biologic therapies targeting tumour necrosis factor‐α on cutaneous mesenchymal stem cells in psoriasis

  2012cited by this paper
• The mesenchymal stem cell profile in psoriasis

  2011cited by this paper
• Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis

  2011cited by this paper
• Human Dermis Harbors Distinct Mesenchymal Stromal Cell Subsets

  2011cited by this paper
• IL-1F5, -F6, -F8, and -F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression

  2011cited by this paper
• Umbilical Cord-Derived Mesenchymal Stromal Cells Modulate Monocyte Function to Suppress T Cell Proliferation

  2010cited by this paper
• Oxidative stress defense in human-skin-derived mesenchymal stem cells versus human keratinocytes: Different mechanisms of protection and cell selection.

  2010cited by this paper
• Differential cytokine secretion of cultured bone marrow stromal cells from patients with psoriasis and healthy volunteers.

  2010cited by this paper
• Skin‐derived mesenchymal stem cells (S‐MSCs) induce endothelial cell activation by paracrine mechanisms

  2010cited by this paper
• New insights in the immunologic basis of psoriasis.

  2010cited by this paper
• IL-33 augments substance P–induced VEGF secretion from human mast cells and is increased in psoriatic skin

  2010cited by this paper
• IL-1RL2 and Its Ligands Contribute to the Cytokine Network in Psoriasis

  2010cited by this paper
• Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1α, and TNF-α Recapitulates Some Features of Psoriasis

  2010cited by this paper
• Molecular dissection of psoriasis: integrating genetics and biology.

  2010cited by this paper
• IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T Cells1

  2009cited by this paper
• IFN-gamma expression in CD8+ T cells regulated by IL-6 signal is involved in superantigen-mediated CD4+ T cell death.

  2009cited by this paper
• T helper 1 to T helper 2 shift in cytokine expression: an autoregulatory process in superantigen-associated psoriasis progression?

  2009cited by this paper
• Contribution of IL-1 to resistance to Streptococcus pneumoniae infection.

  2008cited by this paper
• SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment.

  2008cited by this paper
• The Early Growth Response Factor-1 Is Involved in Stem Cell Factor (SCF)-induced Interleukin 13 Production by Mast Cells, but Is Dispensable for SCF-dependent Mast Cell Growth*

  2007cited by this paper
• The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis

  2007cited by this paper
• Pathogenesis and therapy of psoriasis

  2007cited by this paper
• Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells

  2006cited by this paper
• Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction

  2006cited by this paper
• Receptor Specificity of the Fibroblast Growth Factor Family

  2006cited by this paper
• Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model

  2005cited by this paper
• Phase I/II study of the rituximab-EPOCT regimen in combination with granulocyte colony-stimulating factor in patients with relapsed or refractory follicular lymphoma including evaluation of its cardiotoxicity using B-type natriuretic peptide and troponin T levels.

  2005cited by this paper
• Absence of somatostatin receptors in psoriatic skin lesions

  2004cited by this paper
• Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris

  2004cited by this paper
• Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation.

  2003cited by this paper
• Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction.

  2003cited by this paper
• Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

  2002cited by this paper
• Human adipose tissue is a source of multipotent stem cells.

  2002cited by this paper
• Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p27(kip1).

  2002cited by this paper
• Interleukin-11 induces Th2 polarization of human CD4(+) T cells.

  2001cited by this paper
• Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen.

  2001cited by this paper
• Mesenchymal precursor cells in the blood of normal individuals

  2000cited by this paper
• Inflammatory mediators in normal, sensitive and diseased skin types.

  2000cited by this paper
• Inhibition of Keratinocyte Apoptosis by IL-15: A New Parameter in the Pathogenesis of Psoriasis?1

  2000cited by this paper
• Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis

  1999cited by this paper
• Concentration of an epidermal growth factor in blood serum of males during topical treatment of psoriasis

  1999cited by this paper
• Peripheral blood mononuclear cell proliferative response against staphylococcal superantigens in patients with psoriasis arthropathy.

  1999cited by this paper
• The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.

  1997cited by this paper
• Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts.

  1996cited by this paper
• Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?

  1995cited by this paper
• Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.

  1993cited by this paper

• Nanoformulation of pomegranate peel extract enhances anti-psoriatic efficacy in a rat model.

  2026cites this paper
• Multimodal Function of Mesenchymal Stem Cells in Psoriasis Treatment

  2025cites this paper
• Interleukins and Psoriasis

  2024cites this paper
• Amelioration of exosome and mesenchymal stem cells in rats infected with diabetic nephropathy by attenuating early markers and aquaporin-1 expression.

  2023cites this paper
• Role of Inflammatory Cytokines in Pathophysiology of Psoriasis

  2022cites this paper
• Mesenchymal Stem Cells and Psoriasis: Systematic Review

  2022cites this paper
• Normal mesenchymal stem cells can improve the abnormal function of T cells in psoriasis via upregulating transforming growth factor‐β receptor

  2022cites this paper
• Biomarkers in Oral Fluids as Diagnostic Tool for Psoriasis

  2022cites this paper
• Therapeutic potential of adipose tissue‐derivatives in modern dermatology

  2022cites this paper
• Role of Inflammatory Cytokines in Pathophysiology of Psoriasis

  2022cites this paper
• Dysregulated Dermal Mesenchymal Stem Cell Proliferation and Differentiation Interfered by Glucose Metabolism in Psoriasis

  2021cites this paper
• Dermal Mesenchymal Stem Cells from Psoriatic Lesions Stimulate HaCaT Cell Proliferation, Differentiation, and Migration via Activating the PI3K/AKT Signaling Pathway

  2021cites this paper
• Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases

  2021cites this paper
• Adipose-derived mesenchymal stem cells (AD-MSCs) in the treatment for psoriasis: results of a single-arm pilot trial

  2021cites this paper
• Role of psoriatic keratinocytes in the metabolic reprogramming of dermal mesenchymal stem cells

  2021cites this paper
• Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases

  2021cites this paper
• An Update on the Potential of Mesenchymal Stem Cell Therapy for Cutaneous Diseases

  2021cites this paper
• Role of SPRED1 in keratinocyte proliferation in psoriasis

  2020cites this paper
• Mesenchymal stem cells and psoriasis: State of the art and future perspectives

  2020cites this paper
• Enhanced Inflammation and Nitrosative Stress in the Saliva and Plasma of Patients with Plaque Psoriasis

  2020cites this paper
• Psoriatic Dermal-derived Mesenchymal Stem Cells Reduce Keratinocyte Junctions, and Increase Glycolysis

  2020cites this paper
• Mesenchymal stem cells for the treatment of psoriasis: a comprehensive review

  2020cites this paper
• Characterisation of the circular RNA landscape in mesenchymal stem cells from psoriatic skin lesions

  2019cites this paper
• Mesenchymal Stromal Cells from the Epidermis and Dermis of Psoriasis Patients: Morphology, Immunophenotype, Differentiation Patterns, and Regulation of T Cell Proliferation

  2019cites this paper
• Mesenchymal stem cells in psoriatic lesions affect the skin microenvironment through circular RNA

  2019cites this paper
• Dermal mesenchymal stem cells: a resource of migration-associated function in psoriasis?

  2019cites this paper
• Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives

  2017cites this paper
• Mesenchymal stromal cells: properties and role in management of cutaneous diseases

  2017cites this paper
• Stem cells in psoriasis.

  2017cites this paper
• Increased miR-155-5p expression in dermal mesenchymal stem cells of psoriatic patients: comparing the microRNA expression profile by microarray.

  2016cites this paper
• Expression of pro‐angiogenic genes in mesenchymal stem cells derived from dermis of patients with psoriasis

  2016cites this paper
• Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from Bone Marrow and Skin

  2016cites this paper
• mRNA and protein expression of the angiogenesis‐related genes EDIL3, AMOT and ECM1 in mesenchymal stem cells in psoriatic dermis

  2016cites this paper
• Research Note Mesenchymal stem cells from skin lesions of psoriasis patients promote proliferation and inhibit apoptosis of HaCaT cells.

  2015cites this paper
• An Applied Research in Properties and Clinical Application of Bone Marrow of Mesenchymal Stem Cells

  2015cites this paper
• Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin

  2014cites this paper
• Archives of Stem Cell and Therapy Stem cell secretome-mediated alleviation of scalp psoriasis: A case report

  year unknowncites this paper